|1.||Taché, Yvette: 2 articles (03/2013 - 07/2005)|
|2.||Million, Mulugeta: 2 articles (03/2013 - 07/2005)|
|3.||Bhargava, Aditi: 2 articles (01/2013 - 05/2011)|
|4.||Liao, Min: 2 articles (01/2013 - 05/2011)|
|5.||Kuczyk, Markus A: 2 articles (12/2009 - 03/2009)|
|6.||Tezval, Hossein: 2 articles (12/2009 - 03/2009)|
|7.||Serth, Jürgen: 2 articles (12/2009 - 03/2009)|
|8.||Atschekzei, Farahnaz: 2 articles (12/2009 - 03/2009)|
|9.||Hauger, Richard L: 2 articles (05/2009 - 02/2002)|
|10.||Rivier, Jean: 2 articles (04/2009 - 07/2005)|
04/09/2008 - "This study addressed CRF1 and CRF2 receptor functions and mechanisms in the amygdala in a model of arthritic pain. "
04/03/2013 - "Using a conditioned place aversion (CPA) test, we found that intra-dlBNST injection of a CRF1 or CRF2 receptor antagonist suppressed pain-induced aversion. "
04/09/2008 - "Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior."
06/01/2007 - "Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala."
02/01/2006 - "Peripheral injection of hUcn 2 blunts CRD induced visceral pain, colonic afferent, and spinal L6-S1 ERK 1/2 activity through CRF2 receptor activation in rats."
|3.||Hypertension (High Blood Pressure)
04/01/2009 - "Corticotropin-releasing factor receptor 2 expression was preserved despite chronic stimulation by urocortin 2. In conclusion, our study shows that, in an animal model of arterial hypertension, urocortin 2 has immediate and sustained blood pressure-lowering effects. "
04/01/2009 - "Beneficial effects on blood pressure, left ventricular dimension, and function, together with preserved receptor expression, suggest that corticotropin-releasing factor receptor 2 stimulation by urocortin 2 may represent a novel approach to the treatment of arterial hypertension."
06/01/2007 - "This study determined the effects of CRF1 and CRF2 receptor antagonists in CeLC neurons in an arthritis pain model. "
06/01/2007 - "In contrast, a selective CRF2 receptor antagonist (Astressin-2B; 1-100 microM, 15 min) had no effect in arthritis (n = 7) but increased the neurons' responses under normal conditions (n = 8). "
03/07/2013 - "The down-regulation of the CRF2 receptor in the distal/sigmoid biopsies of UC patients is indicative of change in CRF2 signalling associated with the process of inflammation."
09/01/2008 - "Ucn showed a significant role in the regulation of local inflammation, proliferation, and relaxation of smooth muscle tone in different organs through activation of corticotropin releasing factor receptor 2 (CRFR2). "
01/01/2013 - "Using corticotropin-releasing factor receptor 2-deficient (Crhr2-/-) and wild-type (WT) mice, we show that CRF receptor type 2 (CRF2) and its high-affinity ligand, urocortin 1 (Ucn1), are key mediators of the endoplasmic reticulum (ER) stress response in a murine model of acute pancreatic inflammation. "
|1.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|4.||CRF receptor type 1
|7.||Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)
|8.||Peptide Hormones (Polypeptide Hormones)
|10.||Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)